Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. (2022) Hepatocellular carcinoma. The Lancet [Internet]. [cited 2023 Sep 3] 400 1345–1362. Available from https://linkinghub.elsevier.com/retrieve/pii/S0140673622012004

Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology [Internet]. 2011 [cited 2023 Oct 15] 53 1020–1022. Available from: https://onlinelibrary.wiley.com/doi/https://doi.org/10.1002/hep.24199

Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology [Internet]. 1983 [cited 2020 Sep 3];148:397–401. Available from: https://pubs.rsna.org/doi/abs/https://doi.org/10.1148/radiology.148.2.6306721

Bai H, Meng S, Xiong C, Liu Z, Shi W, Ren Q, et al. Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma. Cardiovasc Intervent Radiol [Internet]. 2022;45:1524–33. Available from: https://doi.org/10.1007/s00270-022-03221-z

Zeng J, Zeng J, Lin K, Lin H, Wu Q, Guo P, et al. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection. Hepatobiliary Surg Nutr [Internet]. 2022 [cited 2022 Sep 5];11:176–87. Available from: https://hbsn.amegroups.com/article/view/51814/html

Yu Y, Fan Y, Wang X, Zhu M, Hu M, Shi C, et al. “Gd-EOB-DTPA-enhanced radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.” Eur Radiol. 2021. https://doi.org/10.1007/s00330-021-08250-9.

Article  PubMed  PubMed Central  Google Scholar 

Kim BK, Kim SU, Kim KA, Chung YE, Kim M-J, Park M-S, et al. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. J Hepatol [Internet]. 2015 [cited 2023 Apr 9];62:1304–10. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168827815000537

Lencioni R, Llovet JM. Modified RECIST (mRECIST) Assessment for hepatocellular carcinoma. Semin LIiver Dis 2010;30(01):52–60. https://doi.org/10.1055/s-0030-1247132

Irie T, Kuramochi M, Takahashi N. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: Measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol. 2013;36:706–13.

Article  PubMed  Google Scholar 

Irie T, Kuramochi M, Kamoshida T, Takahashi N. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super-selective TACE. Hepatol Res. 2016;46:209–14.

Article  PubMed  Google Scholar 

Miyayama S, Yamashiro M, Ikuno M, Okumura K, Yoshida M. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response. Abdom Imaging [Internet]. 2014 [cited 2014 Dec 24];39:645–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24549881

Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer. 2005;103:299–306.

Article  PubMed  Google Scholar 

van Timmeren JE, Leijenaar RTH, van Elmpt W, Reymen B, Oberije C, Monshouwer R, et al. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. Radiotherapy and Oncology [Internet]. 2017;123:363–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167814017301573

Fave X, Mackin D, Yang J, Zhang J, Fried D, Balter P, et al. Can radiomics features be reproducibly measured from CBCT images for patients with non‐small cell lung cancer? Med Phys [Internet]. 2015;42:6784–97. Available from: https://aapm.onlinelibrary.wiley.com/doi/https://doi.org/10.1118/1.4934826

Kobe A, Zgraggen J, Messmer F, Puippe G, Sartoretti T, Alkadhi H, et al. Prediction of treatment response to transarterial radioembolization of liver metastases: Radiomics analysis of pre-treatment cone-beam CT: A proof of concept study. Eur J Radiol Open [Internet]. 2021 [cited 2022 Oct 28];8:100375. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2352047721000551

Tsai Y-C, Shih J-H, Hwang H-E, Chiu N-C, Lee R-C, Tseng H-S, et al. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization. Eur Radiol [Internet]. 2021;31:7464–75. Available from: https://doi.org/10.1007/s00330-021-07843-8

Meng X, Wang Y, Zhou J, Yu Q, Lu C, Xia C, et al. Comparison of <scp>MRI</scp> and <scp>CT</scp> for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma Based on a <scp>Non‐Radiomics</scp> and Radiomics Method: Which Imaging Modality Is Better? Journal of Magnetic Resonance Imaging [Internet]. 2021;54:526–36. Available from: https://onlinelibrary.wiley.com/doi/https://doi.org/10.1002/jmri.27575

Park HJ, Kim JH, Choi S, Lee ES, Park SJ, Byun JY, et al. Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings. American Journal of Roentgenology [Internet]. 2017 [cited 2023 Sep 3];209:W211–20. Available from: https://www.ajronline.org/doi/https://doi.org/10.2214/AJR.16.17398

Kim J, Choi SJ, Lee S-H, Lee HY, Park H. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics. American Journal of Roentgenology [Internet]. 2018 [cited 2023 Sep 3];211:1026–34. Available from: https://www.ajronline.org/doi/https://doi.org/10.2214/AJR.18.19507

Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, et al. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut [Internet]. 2020 [cited 2021 Feb 2];69:1492–501. Available from: https://pubmed.ncbi.nlm.nih.gov/31801872/

Ikeda M, Arai Y, Inaba Y, Tanaka T, Sugawara S, Kodama Y, et al. Conventional or drug-eluting beads? Randomized study of chemo-embolization for hepatocellular carcinoma: JIVROSG-1302. Liver Cancer. 2022;440–50.

Ikeda M, Arai Y, Park SJ, Takeuchi Y, Anai H, Kim JK, et al. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea. J Vasc Interv Radiol [Internet]. 2013;24:490–500. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23466316

Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, et al. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Korean J Intern Med [Internet]. 2016 [cited 2023 Sep 17];31:242–52. Available from: http://kjim.org/journal/view.php?doi=https://doi.org/10.3904/kjim.2015.112

Kim M-Y, Kim JW, Myung D-S, Jun C-H, Lee W-S, Jun Kang Y, et al. Outcomes of Transarterial Chemoembolization With or Without Additional Radiofrequency Ablation in Hepatocellular Carcinoma of 2 to 5 cm in Diameter. Iranian Journal of Radiology [Internet]. 2016 [cited 2023 Sep 17];14:39515. Available from: https://brieflands.com/articles/iranjradiol-13484.html

Endo K, Kuroda H, Oikawa T, Okada Y, Fujiwara Y, Abe T, et al. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma. Scand J Gastroenterol [Internet]. 2018 [cited 2023 Sep 17];53:1575–83. Available from: https://www.tandfonline.com/doi/full/https://doi.org/10.1080/00365521.2018.1548645

Huo YR, Eslick GD. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma. JAMA Oncol [Internet]. 2015 [cited 2023 Sep 18];1:756. Available from: http://oncology.jamanetwork.com/article.aspx?doi=https://doi.org/10.1001/jamaoncol.2015.2189

Miyayama S, Yamashiro M, Hashimoto M, Hashimoto N, Ikuno M, Okumura K, et al. Comparison of Local Control in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma ≤6 cm With or Without Intraprocedural Monitoring of the Embolized Area Using Cone-Beam Computed Tomography. Cardiovasc Intervent Radiol [Internet]. 2014 [cited 2014 Dec 24];37:388–95. Available from: http://link.springer.com/https://doi.org/10.1007/s00270-013-0667-2

Kattipatanapong T, Nishiofuku H, Tanaka T, Sato T, Masada T, Tatsumoto S, et al. Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma. Cardiovasc Intervent Radiol [Internet]. 2020 [cited 2022 Dec 22];43:423–33. Available from: https://link.springer.com/article/https://doi.org/10.1007/s00270-019-02365-9